display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
metastatic/advanced hepatocellular cancer (mHCC)
lung cancer : non small cell (NSCLC)
NTRK gene alteration targeted therapy
entrectinib ALKA-372-001, STARTRK-1, STARTRK-2 ...
larotrectinib Drilon ...

Study type:

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons